The data on 256 non-diabetic patients [11] and with significant hyperlipidaemia [12]. Levels entering renal replacement therapy ( RRT ) in of atherogenic factors such as triglycerides and Lp(a) Manchester between 1 January 1983 and 31 December are high, particularly in patients on haemodialysis [13] 1986 were compared with those on 84 non-diabetic and peritoneal dialysis [14].
Introduction
ficantly lower rates of mortality from ischaemic heart disease than those in such Northern European coun-For over 20 years, there has been evidence to suggest tries as the UK [5] . a causal association between ischaemic heart disease However, it must be remembered that these findings and renal disease [1, 2] .
derive from the data of the EDTA-ERA Registry An increased risk of death from cardiovascular which are reported on an annual basis and it is often disease in patients on renal replacement therapy (RRT ) difficult to be certain of the exact cause of death. This has been confirmed in the past few years [2] [3] [4] [5] [6] [7] and it does not imply criticism of the reporting centres. is now recognized as the main cause of mortality and Without properly documented evidence and especially one of the major causes of morbidity in patients both if the patient has died at home, or in a hospital on dialysis and after transplantation.
unfamiliar with the patient, the precise cause of an From data reported to the EDTA-ERA Registry it apparently 'cardiac' death cannot be determined. accounts for 51% of deaths in patients on haemodia-For these reasons, carefully conducted prospective lysis and 36% of deaths of patients after transplantation studies have a special place, since those conducting [5] . The relative risk of such death is much higher in them take prompt and detailed evidence in each case younger than in older subjects and in those with of death. We have reported such a study in a population diabetes [8] .
of patients who were approaching, or in, terminal renal The factors involved have not been defined. The failure in the Northwest of England [18] , an area in uraemic state affects the heart directly by impairing which therein is documented that the general populacardiomyocytic function [9] and less directly by anaetion is at high risk of developing cardiovascular disease mia, fluid overload, and hypertension which accomin [19] . We found that the incidence was indeed higher pany it [10] . Uraemia is associated with hypertension in patients on RRT than has been reported in the general population [20], but with a decreasing relative We concluded also, that with a well-constructed risk in terms of morbidity and mortality from ischaemic heart disease were present. In each centre, data had been collected on morbidity and mortality in relation to the state at entry to the Clinical definitions renal replacement programme and to the types of RRT Angina pectoris was defined as a typical history of chest pain each patient had received. on exertion with or without confirmation by exercise stress
We confirmed that the diagnostic criteria and the testing or coronary angiography. Myocardial infarction (MI ) definitions employed in studying our patients were was defined as a typical history with either characteristic compatible and established a common database.
ECG findings of acute myocardial infarction or an appro-Although both units accepted diabetic patients who priate rise in serum creatinine phosphokinase levels. were suitable for RRT we have confined this report to Cerebrovascular accident (CVA) was defined as a neurolognon-diabetic patients.
ical deficit transient or permanent, characteristic of that due to vascular disease and in the absence of evidence of an alternative aetiology.
Subjects and methods

Statistical methods
In each centre, one person (GF in Milan and NPV in Manchester) was responsible for the accuracy and com-Kaplan-Meier survival curves [21] were derived and completeness of the data. Any death or event was investigated pared using the logrank test. The following end-points were and the clinical, laboratory and electrocardiographic details used: checked by personal assessment. Postmortem evidence was (i) Cardiovascular death only, all other deaths censored included, if available.
( Figure 1 ). There were no exclusions from consideration in either (ii) Development of angina or of a first myocardial infarccentre and in both, all patients who presented and who were tion, or cardiovascular death, if this was the primary suitable for treatment on medical grounds were placed on event ( Figure 2 ). the programme. The method of RRT deemed most appropriate was used and was changed as necessary. Changes in All data were calculated from the date of first dialysis the mode of RRT were noted and dated. Patients were or the date of transplantation, if that was the first mode transplanted as the occasion arose and follow-up was not of treatment. interrupted.
To adjust for age, Cox proportional hazards regression The data from Manchester concern the subset of 256 nonanalysis [22] was used to compare the patients groups diabetic patients (154 men and 102 women) who began RRT in Manchester and Milan, incorporating a stratification between 1 January 1983 and 31 December 1986 from the for age at the start of RRT in five bands: <35, 35-44, larger group of patients reported previously [18] . In Milan, 45-54, 55-64,>65 years. the data concern the 84 non-diabetic patients (50 male, 34 female) who commenced RRT between 1 January 1983 and 31 December 1988. Thus the studies are not precisely contemporaneous.
On entry to the RRT programme a detailed clinical history and examination was obtained from each patient. Features recorded for this study included age, sex, previous history of myocardial infarction, angina pectoris or other cardiovascular disease, and smoking status (smokers included ex-smokers). The findings are shown in Table 1 .
All patients were followed to the end of the study (that is, a minimum period of 3.5 years) or until death, data being assessed at 31 December 1990 in Manchester and the 31 May 1992 in Milan.
The cause of death was derived from direct assessment of the data and where available, autopsy records and categorized as cardiovascular (EDTA Registry code Fig. 1 . Cardiac deaths only %=Manchester, #=Milan. Time from 11, 13, 14, 15, 16, 18) or other vascular ( EDTA Registry start of renal replacement therapy. Manchester, initial number 256, code 22). Deaths from non-cardiovascular causes were 112 at 5 years, 37 at 7 years; Milan, initial number 84, 46 at 5 years, Cardiovascular disease amongst RRT patients 451 (as a first or subsequent event) or for the development of a new cardiac event (Figures 1 and 2) .
After adjusting for age, the incidence of new cardiac events was not significantly different in the two populations (Hazard Rate ratio 1.5, 95% confidence interval 0.9-2.4, n.s.). The incidence of cardiac death, was higher in Manchester but of borderline significance. (Hazard Rate ratio 1.8, 95% confidence interval 0.9-3.3, P=0.054).
Discussion
In the general population, the incidence of death from Fig. 2 . Time from the start of replacement therapy to a first cardiac ischaemic heart disease appears to vary from country event (whether fatal or not) in patients in the two centres. %= to country. However, it is difficult to attribute these Manchester #=Milan. Number at risk initially in Manchester 256, differences to any single factor such as the diet, when 102 at 5 years, 32 at 7 years; in Milan initially 84, 41 at 5 years, 21 at 7 years; P=0.97.
there are so many contributory factors to consider.
The evidence from the EDTA Registry to suggest that in patients on RRT the incidence of ischaemic heart Results disease in different European areas followed a striking North-South gradient deserves close consideration. Prior to entry to the RRT programme, 11% of Milan It is based on the reports of the cause of death recorded and 10% of Manchester patients had developed angina in the returns of individual units to the Registry. These or had sustained a myocardial infarction and 3-4% of constitute, at best, an approximation. For the reasons each group had sustained a CVA ( Table 1) .
given already, determining the precise reason for a death In Manchester, 154 patients received CAPD as the in a patient on RRT is both complex and timefirst form of RRT, 15 switching later to haemodialysis;
consuming. That it is difficult to obtain validated data, 79 patients were maintained on HD as the only form especially in retrospect, is readily understandable. of dialysis, 23 patients were transplanted without having Interestingly, evidence from the United States highreceived prior dialysis. In all, 154 of the 256 patients lights the fact that the cause of death reported may be were transplanted. In Milan, 64 patients were placed on different from that recorded in the death certificate [23] . HD and 20 on CAPD. None were transplanted before Furthermore, morbidity as well as mortality should be dialysis; 22 were transplanted during the study.
assessed. This requires informed and prospective study. The status at the end of the study is given in Table 2 .
It is because our units had carried out such studies 'Other vascular' deaths include cerebrovascular events.
that we chose to analyse the data together. These 'Other' deaths were due to infection in seven cases, reveal that, in terms of morbidity before RRT comcachexia predominantly in patients with advanced vasmenced, morbidity and mortality while on RRT, and culopathy or malignancy (6 cases each) and in four overall survival (which appears acceptable) there is cases to dementia in patients with diffuse cerebrovasculittle to choose between the patient groups which lar disease. One patient suffering from Christmas dispresented to the two units. ease had intractable bleeding and one died after severe Neither exercised a selection policy in relation to haematemesis not otherwise defined. One patient died offering RRT to patients presenting in renal failure, from chronic airways limitation and one from immediother than that of clinical benefit. In each, the patients ate post-transplant complications. In two patients the were drawn from the local districts. cause of death was not known.
One feature of our analysis was that the pattern of During the study, 18% of Milan and 11% of morbidity from ischaemic heart disease was similar in Manchester patients developed angina or sustained a both cohorts either before or after RRT had comnon-fatal myocardial infarction, while 7% of Milan menced. While the two populations were too small to and 12% of Manchester patients died from a first make definitive statements as to the significance of the cardiovascular event.
observation, it demonstrates how important is a careful For these non-diabetic patients, actuarial survival is assessment of existing morbidity in any patient entering not different in the two populations, for cardiac deaths the renal replacement programme. Age has an influence on cardiovascular outcome in There has been interest recently in the role of even moderate hypertension as a factor in increasing the References rate at which, over a prolonged period of haemodia- prospective study, in which it would be imperative to 35-64 years. World Health Stat Q 1988; 41: 115-136 assess in detail the morbidity in each patient prior to 16. Ibels LS, Stewart JH, Mahony JF, Shiel AGR. Death from entry to the RRT programme. occlusive arterial disease in renal allograft recipients. Br Med J 1974; 3: 552-554 Each event must be detailed promptly and in case of 17. Kasiske BL. Risk factors for accelerated atherosclerosis in renal death, postmortem evidence obtained as often as possible. transplant recipients. Am J Med 1988; 84: 985-992 In summary, we present data, collected prospectively, 18. Brown JH, Hunt LP, Vites NP, Short CD, Gokal R, Mallick NP. which suggest strongly to us that previous reports on the Comparative mortality from cardiovascular disease in patients with chronic renal failure. Nephrol Dial Transplant 1994; 9: differential incidence of ischaemic heart disease in patients [1136] [1137] [1138] [1139] [1140] [1141] [1142] on RRT in North and South European countries must 19. Shaper AG, Pocock SJ, Walker M, Cohen NM, Wade AJ, be evaluated with caution, since they have been obtained Thomson AG. British Regional Heart Study: Cardiovascular from records in which data are entered by different risk factors in middle aged men in 24 towns. Br Med J 1981; 283: 177-186 people, sometimes well after the events.
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It should be remembered too, that the arbitrary DH5 1983 DH5 -1990 . HMSO, London division of Europe into 'North' and 'South' can mis-21. Kaplan EL, Meier P. Non-parametric estimation from incomlead. In the general population, the reported incidence
